title: Increased Monday incidence of life-threatening ventricular arrhythmias. Experience with a third-generation implantable defibrillator.
abstract: BACKGROUND
  Examination of the timing of cardiac events provides important pathophysiological information. Previous studies have shown that the onset of acute myocardial infarction occurs most frequently on Monday. The septadian (day of the week) pattern of occurrence of sudden cardiac death and lethal ventricular arrhythmias has not been examined previously.
  
  
  RESULTS
  We examined the septadian distribution of life-threatening (cycle length < 280 ms) ventricular arrhythmias in 683 consecutive patients receiving a Ventak PRx, a third-generation implantable defibrillator with an event recorder. There was a prominent Monday peak, with a midweek decline and a secondary peak later in the week. A marked trough is apparent on both weekend days. The observed pattern was independent of age, sex, ejection fraction, NYHA functional class, type of heart disease, and the use of antiarrhythmic drugs but was not observed in patients receiving beta-blockers.
  
  
  CONCLUSIONS
  Potentially lethal arrhythmias are not random events but occur in a daily pattern suggesting a relationship to the beginning and end of the work week. The absence of a Monday peak in patients receiving beta-blockers suggests that the pattern may be influenced by beta-blockers. This information may be useful in devising strategies to prevent sudden cardiac death.
authors.affiliation: Department of Medicine, University of Maryland School of Medicine, Baltimore, USA. Robert W Peters, MD@Baltimore. Gov
authors.forename: R W
authors.initials: RW
authors.lastname: Peters
authors.forename: S
authors.initials: S
authors.lastname: McQuillan
authors.forename: S K
authors.initials: SK
authors.lastname: Resnick
authors.forename: M R
authors.initials: MR
authors.lastname: Gold
mesh_terms: D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D017147:Defibrillators, Implantable; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D017180:Tachycardia, Ventricular / Q000453:epidemiology* / Q000628:therapy; D013997:Time Factors; D014937:Work
chemical_list: D000889:Anti-Arrhythmia Agents